1. Aortic valve calcium in relation to subclinical cardiac dysfunction and risk of heart failure in the general population. (3rd October 2022) Authors: Zhu, F; Kaiser, Y; Boersma, H; Bos, D; Kavousi, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lipoprotein(a) is a strong risk factor for Aortic Valve Calcium. (25th November 2020) Authors: Kaiser, Y; Singh, S.S; Zheng, K.H; Verbeek, R; Kavousi, M; Pinto-Sietsma, S; Sijbrands, E.J.G; Boekholdt, S.M; De Rijke, Y.B; Stroes, E.S.G; Bos, D Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lipoprotein(a) is associated with incidence but not progression of aortic valve calcium. (14th October 2021) Authors: Kaiser, Y; Van Der Toorn, J E; Zheng, K H; Kavousi, M; Vernooij, M W; Sijbrands, E J G; Boekholdt, S M; Stroes, E S G; De Rijke, Y B; Bos, D Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗